Intralesional and subcutaneous application of Viscum album L. (European mistletoe) extract in cervical carcinoma in situ

Antioxidant Activity of European Mistletoe (Viscum album)

Immunologic Response to Mistletoe Extract (Viscum album L.) after Conventional Treatment in Patients with Operable Breast

During treatment of cancer, some side effects of conventional treatment may limit the ability of the patient to receive the full course of therapy. To reduce the side effects and improve the effectiveness of standard therapy, many complementary or alternative medicines (CAM) have been tried in patient with a variety of cancers. Mistletoe extracts are among commonly prescribed CAM for cancer pat...

Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines.

Head and neck squamous cell carcinoma is a complex disease with several etiologic factors and different molecular changes that may trigger certain events; it is also globally one of the most common malignancies in this topography. Extracts from Viscum album L. (VA) (mistletoe) have been used as adjuvant therapies with promising results in several types of cancer, mainly in European countries. I...

Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study

Background. Traditional mistletoe therapy in cancer patients involves subcutaneous applications of Viscum album L. preparations, with doses slowly increasing based on patient responses. Intravenous infusion of high doses may improve therapeutic outcomes and is becoming more common. Little is known about the safety of this "off-label" application of mistletoe. Methods. An observational study was...

Intrapleural Instillation of a Viscum album (L.) Extract (Mistletoe) for the Treatment of Malignant Pleural Effusions